Frontlight ResearchEarly access
Trial site
Fundación CORI para la Investigación y Prevención del Cáncer
- 8running trials
- 2closed trials
The trials here
What the 10 trials at this site are about, from their registry records.
- Conditions
- Metastatic breast cancer4 trials
- Colorectal cancer2 trials
- Lung cancer2 trials
- Bladder cancer1 trial
- Gastric and oesophageal cancer1 trial
- Head and neck cancer1 trial
- Liver and biliary tract cancer1 trial
- Prostate cancer1 trial
- Sarcoma1 trial
- Phase
- Phase 37 trials
- Phase 23 trials
- Status
- Active, not recruiting4 trials
- Recruiting4 trials
- Completed2 trials
- Lead sponsor
- Pfizer5 trials
- Adlai Nortye Biopharma Co., Ltd.1 trial
- BeOne Medicines1 trial
- BicycleTx Limited1 trial
- Eli Lilly and Company1 trial
- and 1 more
Running trials
Recruiting
Recruiting
Recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Study BT8009-230 in Participants With Locally Advanced or Metastatic Urothelial Cancer (Duravelo-2)
Recruiting
Study to Test the Safety and Tolerability of PF-07220060 in Participants With Advance Solid Tumors
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Colorectal cancer1 recruiting
- Gastric and oesophageal cancer1 recruiting
- Lung cancer1 recruiting
- Metastatic breast cancer1 recruiting
Closed trials
Recruiting
Completed
The BURAN Study of Buparlisib in Patients With Recurrent or Metastatic HNSCC
Site data: ClinicalTrials.govUpdated 12 Nov 2026